News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,723 Results
Type
Article (45286)
Company Profile (279)
Press Release (665158)
Section
Business (206580)
Career Advice (2180)
Deals (35691)
Drug Delivery (97)
Drug Development (82657)
Employer Resources (177)
FDA (16357)
Job Trends (15047)
News (350008)
Policy (33299)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2700)
Accelerated approval (2)
Adcomms (21)
Allergies (80)
Alliances (50353)
ALS (84)
Alzheimer's disease (1379)
Antibody-drug conjugate (ADC) (110)
Approvals (16358)
Artificial intelligence (240)
Autoimmune disease (14)
Automation (14)
Bankruptcy (365)
Best Places to Work (11791)
BIOSECURE Act (18)
Biosimilars (105)
Biotechnology (202)
Bladder cancer (57)
Brain cancer (24)
Breast cancer (247)
Cancer (1990)
Cardiovascular disease (155)
Career advice (1813)
Career pathing (31)
CAR-T (142)
Cell therapy (401)
Cervical cancer (19)
Clinical research (66686)
Collaboration (780)
Compensation (446)
Complete response letters (19)
COVID-19 (2695)
CRISPR (34)
C-suite (204)
Cystic fibrosis (99)
Data (1943)
Decentralized trials (2)
Denatured (18)
Depression (36)
Diabetes (248)
Diagnostics (6406)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (113)
Drug pricing (98)
Drug shortages (26)
Duchenne muscular dystrophy (85)
Earnings (86551)
Editorial (34)
Employer branding (22)
Employer resources (150)
Events (113078)
Executive appointments (633)
FDA (17462)
Featured Employer (52)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (698)
Gene editing (96)
Generative AI (22)
Gene therapy (278)
GLP-1 (696)
Government (4562)
Grass and pollen (4)
Guidances (48)
Healthcare (19115)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (109)
Indications (26)
Infectious disease (2831)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (83)
Interviews (345)
IPO (16600)
IRA (42)
Job creations (3687)
Job search strategy (1540)
Kidney cancer (9)
Labor market (35)
Layoffs (464)
Leadership (17)
Legal (8037)
Liver cancer (71)
Lung cancer (293)
Lymphoma (130)
Machine learning (2)
Management (60)
Manufacturing (266)
MASH (61)
Medical device (13438)
Medtech (13443)
Mergers & acquisitions (19554)
Metabolic disorders (635)
Multiple sclerosis (70)
NASH (17)
Neurodegenerative disease (79)
Neuropsychiatric disorders (24)
Neuroscience (1849)
NextGen: Class of 2025 (6648)
Non-profit (4587)
Northern California (2407)
Now hiring (37)
Obesity (342)
Opinion (215)
Ovarian cancer (72)
Pain (76)
Pancreatic cancer (77)
Parkinson's disease (132)
Partnered (20)
Patents (203)
Patient recruitment (94)
Peanut (46)
People (57848)
Pharmaceutical (65)
Pharmacy benefit managers (19)
Phase I (21011)
Phase II (29292)
Phase III (21758)
Pipeline (981)
Podcasts (47)
Policy (111)
Postmarket research (2602)
Preclinical (9039)
Press Release (68)
Prostate cancer (93)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (360)
Real estate (5973)
Recruiting (67)
Regulatory (22655)
Reports (47)
Research institute (2447)
Resumes & cover letters (383)
Rett syndrome (3)
RNA editing (3)
RSV (38)
Schizophrenia (62)
Series A (125)
Series B (79)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2077)
Special edition (14)
Spinal muscular atrophy (155)
Sponsored (28)
Startups (3672)
State (2)
Stomach cancer (12)
Supply chain (60)
The Weekly (26)
United States (21129)
Vaccines (680)
Venture capitalists (37)
Webinars (12)
Weight loss (226)
Women's health (33)
Worklife (15)
Date
Today (82)
Last 7 days (610)
Last 30 days (2518)
Last 365 days (34002)
2025 (7815)
2024 (35700)
2023 (40581)
2022 (51812)
2021 (56317)
2020 (54816)
2019 (47274)
2018 (35641)
2017 (32730)
2016 (32302)
2015 (38283)
2014 (32055)
2013 (27364)
2012 (29430)
2011 (30043)
2010 (28013)
Location
Africa (777)
Alabama (49)
Alaska (7)
Arizona (226)
Arkansas (14)
Asia (39035)
Australia (6532)
California (5499)
Canada (1862)
China (473)
Colorado (248)
Connecticut (258)
Delaware (124)
Europe (84502)
Florida (809)
Georgia (190)
Hawaii (1)
Idaho (58)
Illinois (497)
India (23)
Indiana (292)
Iowa (9)
Japan (140)
Kansas (100)
Kentucky (25)
Louisiana (9)
Maine (60)
Maryland (848)
Massachusetts (4155)
Michigan (224)
Minnesota (372)
Mississippi (2)
Missouri (76)
Montana (31)
Nebraska (25)
Nevada (56)
New Hampshire (64)
New Jersey (1565)
New Mexico (30)
New York (1579)
North Carolina (926)
North Dakota (7)
Northern California (2407)
Ohio (190)
Oklahoma (14)
Oregon (34)
Pennsylvania (1252)
Puerto Rico (9)
Rhode Island (26)
South America (1136)
South Carolina (18)
South Dakota (1)
Southern California (2077)
Tennessee (93)
Texas (819)
Utah (163)
Virginia (131)
Washington D.C. (59)
Washington State (511)
West Virginia (3)
Wisconsin (50)
710,723 Results for "human longevity inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AgelessRx Expands Offerings to Include Oral GLP-1 Drops to Advance Metabolic Health and Longevity Science
February 5, 2025
·
4 min read
Press Releases
Rimkus Acquires Human Factors Consulting Services, Incorporated, Enhancing Expertise in Human Factors and Medical Device Consulting
March 6, 2025
·
2 min read
Press Releases
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
February 20, 2025
·
2 min read
Press Releases
Vivos Inc. Reports Encouraging Human Clinical Trial Results and Announces Expansion Plans
February 4, 2025
·
5 min read
Press Releases
Jupiter Neurosciences and Aquanova AG Announce Strategic Collaboration to Develop Longevity and Healthspan Products
March 4, 2025
·
5 min read
Pharm Country
ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene
ANEW MEDICAL, INC. announces a strategic partnership with Drs. Makoto Suzuki, Craig and Bradley Willcox, Richard Allsopp, and Michio Shimabukuro of Japan’s Okinawa Research Center for Longevity Science for the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.
June 27, 2024
·
6 min read
Press Releases
Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines
February 26, 2025
·
7 min read
Press Releases
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
November 21, 2024
·
7 min read
Press Releases
Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial
December 23, 2024
·
6 min read
Press Releases
Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells
March 19, 2025
·
6 min read
1 of 71,073
Next
